Some studies found that hormone replace therapy (HRT) had no significant impact on lipid profiles.[4] Recent studies focus on the association between FSH and cardiometabolic factors including serum lipids, but the results are controversial whether FSH is negatively or positively associated with dyslipidemia in postmenopausal women. This evidence concerns the gene BRD2 and metabolic syndrome.